🇺🇸 FDA
Patent

US 9351968

Methods of treating developmental disorders using pipradrol

granted A61KA61K31/4453A61K31/4458

Quick answer

US patent 9351968 (Methods of treating developmental disorders using pipradrol) held by OVID THERAPEUTICS INC. expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/4453, A61K31/4458, A61K45/06, A61P